Navigation Links
UCI researchers create new strategy for highly-selective chemotherapy delivery
Date:9/24/2009

Irvine, Calif. UC Irvine researchers have created a new approach that vastly improves the targeting of chemotherapeutic drugs to specific cells and organs.

Kenneth Longmuir, associate professor of physiology & biophysics, and Richard Robertson, professor of anatomy & neurobiology, used liposomes, small spheres (less-than 100 nanometer in diameter) of naturally-occurring lipid molecules, as "packages" for the cancer chemotherapeutic agent doxorubicin, and a small peptide molecule to "address" the package to the targeted tissue.

Using this technology, the research team demonstrated that the doxorubicin was directed almost entirely to the targeted site with virtually no uptake by other organs, including lung, kidney and heart.

Their study appears online in the International Journal of Pharmaceutics.

Their approach is based on the fact that all tissues and organs, including all tumors, are surrounded by a dense region of sugar-containing molecules called polysaccharides. Most importantly, the particular chemical composition of the polysaccharides is different in each tissue and organ of the body. The chemical compositions of the polysaccharides of tumor regions are also different from normal tissue.

The research team developed a nanocarrier system that can recognize specific types of polysaccharide, and has demonstrated effective, organ-specific delivery of nanocarriers, and their therapeutic contents, based upon this polysaccharide-targeting approach.

In their study, the researchers used a peptide derived from a protein found in the microorganism Plasmodium, which is an organism well-known for its exceptional ability to exclusively target the polysaccharides of liver following entry into the bloodstream.

The drug doxorubicin is a chemotherapeutic agent commonly used as treatment for a variety of cancers. Although it is an effective anti-cancer agent, the usefulness of doxorubicin is compro
'/>"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy
2. VA Honors Eye Researchers With Olin Teague Award
3. Researchers find drug-eluting stents safe, effective for PCI in diabetics
4. Researchers Propose Improved Cervical Cancer Screening
5. Researchers Perfect the View of Heart Disease
6. Mayo Clinic researchers lead national trial testing new treatment for chronic, severe indigestion
7. Indiana U medical researchers boost research and jobs with stimulus legislation grants
8. Canadian researchers discover the first-ever link between intelligence and curiosity
9. MUSC Researchers Concerned About Online Drug Availability
10. UCLA researchers develop biomarker for rapid relief of major depression
11. UCSB researchers develop drug delivery system using nanoparticles and lasers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013 Idol lash has designed ... darker and fuller eyelashes in a matter of few weeks. ... online purchase with an extra pack offer to help more ... access this offer on the Idol lash official website. , ... increase the eyelash density up to 82% in just a ...
(Date:5/20/2013)... 20, 2013 The US Drug ... of a transvaginal mesh failure, we are now calling ... we have ever seen for women, and the damages ... a potentially huge number of US women. According to ... underwent procedures in which mesh was implanted vaginally to ...
(Date:5/20/2013)... Atlanta, GA (PRWEB) May 20, 2013 ... Vision Institute published a testimonial about how one of ... for a LASIK consultation after being diagnosed with giant ... a foreign object in the eye, and for one ... lenses that caused this allergy,” says the Medical Director ...
(Date:5/20/2013)... 2013 The Mesothelioma Victims Center ... Navy Veterans who are diagnosed with mesothelioma get shortchanged ... they, or their family members turned to a local ... of the most skilled, and experienced mesothelioma lawyers in ... mesothelioma in the US never even bother to explore ...
(Date:5/20/2013)... 20, 2013 Milpitas, Los Angeles, ... leader in enterprise-class information archiving, eDiscovery and migration ... 7.0, the latest release in the MessageSolution product ... the legal discovery lifecycle. MessageSolution will exhibit at ... CA. , As the first stop of the ...
Breaking Medicine News(10 mins):Health News:Idol Lash Eyelash Growth Enhancer Now Offered Extra Pack for Limited Time Only at HealthCareSupplementz.com 2Health News:US Drug Watchdog Now Urges Transvaginal Mesh Failure Victims With Erosion To Call Them For The Names And Contacts Of The Best Women Attorneys 2Health News:Atlanta LASIK Practice Publishes a Patient’s Testimonial About Allergy to Contact Lenses 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For The Names Of The Nation's Best Mesothelioma Lawyers-Better Compensation 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For The Names Of The Nation's Best Mesothelioma Lawyers-Better Compensation 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 2Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 4
... The advantage that children get from living in two-parent families ... fact that their parents are married. A new study ... in stable single-parent homes generally do as well as those ... problems. "Many of the studies that show an advantage ...
... , , , ... antimicrobial skin care company, announced today that an independent testing laboratory ... H1N1 flu virus. The test results show HandClens is 99.99% ... submit these results to the FDA as an addendum to its ...
... , , NEW YORK, Aug. ... according to The Conference Board Help-Wanted OnLine Data Series (HWOL)(TM) ... with many of the largest States now showing stable trends following about ... data, there are now three States (New York, Maryland and Virginia) where ...
... , , GREENWICH, Conn., Aug. 31 ... system for treatment of bowel incontinence. Secca Therapy is ... that affects tens of millions of Americans, both young and ... of the anal canal - tightening the muscles, producing better ...
... , , , ... WTW ) announced today the start of the second annual Lose ... obesity and hunger. Between August 30th and October 17th, as Weight ... to $1 million to two hunger fighting organizations - Share Our Strength ...
... Italy, August 31 Health Robotics today announced,that ... agreed to,immediately install its flagship CytoCare Robot during ... an exclusive 3-year distribution,licensing, and support contract with ... and Pinnaclemed desire to safely, accurately, and,cost-effectively automate ...
Cached Medicine News:Health News:Family stability may be more crucial than 2 parents for child success 2Health News:Family stability may be more crucial than 2 parents for child success 3Health News:Tests Confirm HandClens(R) Hand Sanitizer Kills H1N1 Flu Virus 2Health News:Tests Confirm HandClens(R) Hand Sanitizer Kills H1N1 Flu Virus 3Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 2Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 3Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 4Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 5Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 6Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 7Health News:Secca(R) Therapy - An Effective and Minimally Invasive Option for Treating Bowel Incontinence - Launched in the US 2Health News:Weight Watchers Launches Second Annual Lose For Good(TM) Campaign 2Health News:Weight Watchers Launches Second Annual Lose For Good(TM) Campaign 3Health News:Weight Watchers Launches Second Annual Lose For Good(TM) Campaign 4Health News:Weight Watchers Launches Second Annual Lose For Good(TM) Campaign 5Health News:Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed 2Health News:Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed 3Health News:Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed 4
(Date:5/17/2013)... , May 17, 2013  Sony Biotechnology Inc. ("Sony") ... Spectral Analyzer (SP6800).  Sony will be exhibiting and taking ... be held at the San Diego ... , from May 20 - 22.  ... system, incorporating commercial audio-visual technologies into new and novel ...
(Date:5/17/2013)... , May 17, 2013  TechAtlas Group ... for their competitive landscape map for the Chronic ... over 90 international companies with drugs and devices ... CKD and its sequelae. (Logo:  ... , hypertension - renal denervation ...
(Date:5/17/2013)... Puerto Rico , May 17, 2013  Serving a ... Puerto Rico , Caribbean Imaging and Radiation Therapy ... its radiation therapy capabilities with the acquisition of an Elekta ... . Versa HD offers clinicians the versatility to deliver ... the body, while also enabling treatment of highly complex cancers ...
Breaking Medicine Technology:Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2
... the FDA announced,approval for the first clinical trials on ... Christian Drapeau says the experts may not be,telling the ... less,risk. , "While the FDA ... the shackles of politics," said Drapeau. "The expert commentary ...
... of MSI-1436 in DIO Rats Highlighted -PLYMOUTH MEETING, ... Corporation (Nasdaq: GENR ) today announced ... (MSI-1436), Genaera,s lead drug candidate for the treatment ... Keystone Symposia: Obesity - Novel Aspects of the ...
Cached Medicine Technology:FDA Stem Cell Approval Breakthrough Laudable 2Genaera Presents Promising Preclinical Data for Trodusquemine (MSI-1436) at Keystone Symposia 2Genaera Presents Promising Preclinical Data for Trodusquemine (MSI-1436) at Keystone Symposia 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 6.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 11.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 8 mm....
Medicine Products: